Sign in to view content

Two-Year Results From the Subretinal RGX-314 Gene Therapy Phase 1/2a Study for the Treatment of Neovascular AMD

Robert L. Avery, MD

Video
Published 2021

Related

The OASIS Trial: Natural History of Symptomatic Vitreomacular Adhesion
Joseph M. Coney, MD, FASRS
Annual Meeting Talks
2016
Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history
Jayanth Sridhar, MD
Member Podcasts
2018
Real World Patient and Clinical Characteristics in Treatment Naive Neovascular Age-Related Macular Degeneration
Matthew P. Ohr, MD
On Demand Cases, Courses, and Papers
2019

Category: AMD-Neovascular

See more